<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>kreisch | Bowers Jokumsen | Activity</title>
	<link>https://kreisch.ch/members/monkeyvelvet1/activity/</link>
	<atom:link href="https://kreisch.ch/members/monkeyvelvet1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Aktivitäts-Feed für Bowers Jokumsen.</description>
	<lastBuildDate>Mon, 17 Aug 2026 08:02:24 +0200</lastBuildDate>
	<generator>https://buddypress.org/?v=10.6.0</generator>
	<language>de</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3e17558c1d82f1b13afd6778ad15a212</guid>
				<title>Bowers Jokumsen postete ein Update: It is currently utilized as a great resistant reconstitution [&#133;]</title>
				<link>https://kreisch.ch/activity/p/7779/</link>
				<pubDate>Sun, 15 Jan 2023 19:40:31 +0100</pubDate>

									<content:encoded><![CDATA[<p>It is currently utilized as a great resistant reconstitution therapy in patients along with relapsing-remitting ms. Alemtuzumab treatment is an infusion that triggers long-term remission of Multiple Sclerosis and in your treatment-free time period. Following your powerful To along with N cellular exhaustion caused simply by alemtuzumab, your&hellip;<span class="activity-read-more" id="activity-read-more-7779"><a href="https://kreisch.ch/activity/p/7779/" rel="nofollow ugc">[Weiterlesen]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">74fbd2f9c3e4378ea671d2ee0431cb20</guid>
				<title>Bowers Jokumsen wurde ein Mitglied</title>
				<link>https://kreisch.ch/activity/p/7767/</link>
				<pubDate>Sun, 15 Jan 2023 19:32:17 +0100</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>